Gene Biotherapeutics Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Chris Reinhard
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 20.4yrs |
| CEO ownership | n/a |
| Management average tenure | 4yrs |
| Board average tenure | 17.5yrs |
Recent management updates
No updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2020 | US$240k | US$240k | -US$518k |
| Sep 30 2020 | n/a | n/a | US$1m |
| Jun 30 2020 | n/a | n/a | US$2m |
| Mar 31 2020 | n/a | n/a | US$943k |
| Dec 31 2019 | US$239k | US$239k | US$867k |
| Dec 31 2018 | US$235k | US$235k | -US$435k |
| Dec 31 2017 | US$234k | US$234k | -US$2m |
Compensation vs Market: Insufficient data to establish whether Chris's total compensation is reasonable compared to companies of similar size in the US market.
Compensation vs Earnings: Insufficient data to compare Chris's compensation with company performance.
CEO
Chris Reinhard (69 yo)
20.4yrs
Tenure
US$240,000
Compensation
Mr. Christopher J. Reinhard is also known as Chris, has been Chief Executive Officer, President, Executive Director and Treasurer of Gene Biotherapeutics, Inc. (formerly known as Taxus Cardium Pharmaceutic...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 20.4yrs | US$240.00k | no data | |
| Chairman | 4yrs | no data | no data | |
| Chief Operating Officer | 4yrs | no data | no data | |
| Chief Scientific Officer | 4yrs | no data | no data | |
| General Counsel | no data | US$133.66k | no data |
4.0yrs
Average Tenure
68.5yo
Average Age
Experienced Management: CRXM's management team is considered experienced (4 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 20.4yrs | US$240.00k | no data | |
| Chairman | 4yrs | no data | no data | |
| Member of Scientific Advisory Board | 17.5yrs | no data | no data | |
| Member of Scientific Advisory Board | 17.5yrs | no data | no data | |
| Member of the Scientific Advisory Board | 16yrs | no data | no data | |
| Chairman of Scientific Advisory Board | 17.5yrs | US$244.28k | no data | |
| Member of Scientific Advisory Board | 17.8yrs | no data | no data | |
| Member of Scientific Advisory Board | 17.5yrs | no data | no data | |
| Member of Scientific Advisory Board | 17.5yrs | no data | no data | |
| Independent Director | 4yrs | no data | no data |
17.5yrs
Average Tenure
68.5yo
Average Age
Experienced Board: CRXM's board of directors are seasoned and experienced ( 17.5 years average tenure).